Literature DB >> 31019093

Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD.

Rodrigo Lopez-Gonzalez1, Dejun Yang1, Mochtar Pribadi2, Tanya S Kim2, Gopinath Krishnan1, So Yoen Choi1, Soojin Lee1, Giovanni Coppola2, Fen-Biao Gao3.   

Abstract

GGGGCC (G4C2) repeat expansion in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). One class of major pathogenic molecules in C9ORF72-ALS/FTD is dipeptide repeat proteins such as poly(GR), whose toxicity has been well documented in cellular and animal models. However, it is not known how poly(GR) toxicity can be alleviated, especially in patient neurons. Using Drosophila as a model system in an unbiased genetic screen, we identified a number of genetic modifiers of poly(GR) toxicity. Surprisingly, partial loss of function of Ku80, an essential DNA repair protein, suppressed poly(GR)-induced retinal degeneration in flies. Ku80 expression was greatly elevated in flies expressing poly(GR) and in C9ORF72 iPSC-derived patient neurons. As a result, the levels of phosphorylated ATM and P53 as well as other downstream proapoptotic proteins such as PUMA, Bax, and cleaved caspase-3 were all significantly increased in C9ORF72 patient neurons. The increase in the levels of Ku80 and some downstream signaling proteins was prevented by CRISPR-Cas9-mediated deletion of expanded G4C2 repeats. More importantly, partial loss of function of Ku80 in these neurons through CRISPR/Cas9-mediated ablation or small RNAs-mediated knockdown suppressed the apoptotic pathway. Thus, partial inhibition of the overactivated Ku80-dependent DNA repair pathway is a promising therapeutic approach in C9ORF72-ALS/FTD.

Entities:  

Keywords:  ALS/FTD; C9ORF72; DNA damage; Drosophila; iPSC

Mesh:

Substances:

Year:  2019        PMID: 31019093      PMCID: PMC6511021          DOI: 10.1073/pnas.1901313116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  36 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 2.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

3.  Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.

Authors:  Peter E A Ash; Kevin F Bieniek; Tania F Gendron; Thomas Caulfield; Wen-Lang Lin; Mariely Dejesus-Hernandez; Marka M van Blitterswijk; Karen Jansen-West; Joseph W Paul; Rosa Rademakers; Kevin B Boylan; Dennis W Dickson; Leonard Petrucelli
Journal:  Neuron       Date:  2013-02-12       Impact factor: 17.173

4.  Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.

Authors:  Dhruv Sareen; Jacqueline G O'Rourke; Pratap Meera; A K M G Muhammad; Sharday Grant; Megan Simpkinson; Shaughn Bell; Sharon Carmona; Loren Ornelas; Anais Sahabian; Tania Gendron; Leonard Petrucelli; Michael Baughn; John Ravits; Matthew B Harms; Frank Rigo; C Frank Bennett; Thomas S Otis; Clive N Svendsen; Robert H Baloh
Journal:  Sci Transl Med       Date:  2013-10-23       Impact factor: 17.956

Review 5.  DNA damage and its links to neurodegeneration.

Authors:  Ram Madabhushi; Ling Pan; Li-Huei Tsai
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

6.  The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

Authors:  Kohji Mori; Shih-Ming Weng; Thomas Arzberger; Stephanie May; Kristin Rentzsch; Elisabeth Kremmer; Bettina Schmid; Hans A Kretzschmar; Marc Cruts; Christine Van Broeckhoven; Christian Haass; Dieter Edbauer
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

7.  Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells.

Authors:  Maximiliano A D'Angelo; Marcela Raices; Siler H Panowski; Martin W Hetzer
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.

Authors:  Tao Zu; Yuanjing Liu; Monica Bañez-Coronel; Tammy Reid; Olga Pletnikova; Jada Lewis; Timothy M Miller; Matthew B Harms; Annet E Falchook; S H Subramony; Lyle W Ostrow; Jeffrey D Rothstein; Juan C Troncoso; Laura P W Ranum
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

9.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

10.  Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons.

Authors:  Sandra Almeida; Eduardo Gascon; Hélène Tran; Hsin Jung Chou; Tania F Gendron; Steven Degroot; Andrew R Tapper; Chantal Sellier; Nicolas Charlet-Berguerand; Anna Karydas; William W Seeley; Adam L Boxer; Leonard Petrucelli; Bruce L Miller; Fen-Biao Gao
Journal:  Acta Neuropathol       Date:  2013-07-09       Impact factor: 17.088

View more
  32 in total

Review 1.  DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases.

Authors:  Nidheesh Thadathil; Roderick Hori; Jianfeng Xiao; Mohammad Moshahid Khan
Journal:  Chromosome Res       Date:  2019-11-09       Impact factor: 5.239

Review 2.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

Review 3.  CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders.

Authors:  Lihong Guan; Yawei Han; Ciqing Yang; Suxiang Lu; Jiang Du; Han Li; Juntang Lin
Journal:  Mol Neurobiol       Date:  2021-11-23       Impact factor: 5.590

4.  C9orf72 functions in the nucleus to regulate DNA damage repair.

Authors:  Liying He; Jiaqi Liang; Chaonan Chen; Jijun Chen; Yihui Shen; Shuangshuang Sun; Lei Li
Journal:  Cell Death Differ       Date:  2022-10-11       Impact factor: 12.067

5.  Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.

Authors:  Shuangxi Li; Zhihao Wu; Ishaq Tantray; Yu Li; Songjie Chen; Jason Dong; Steven Glynn; Hannes Vogel; Michael Snyder; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 6.  Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges.

Authors:  Annarita Miccio; Panagiotis Antoniou; Sorana Ciura; Edor Kabashi
Journal:  Mol Ther       Date:  2021-04-03       Impact factor: 11.454

Review 7.  Gene therapy for ALS: A review.

Authors:  Defne A Amado; Beverly L Davidson
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

8.  Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.

Authors:  Nidaa A Ababneh; Jakub Scaber; Rowan Flynn; Andrew Douglas; Paola Barbagallo; Ana Candalija; Martin R Turner; David Sims; Ruxandra Dafinca; Sally A Cowley; Kevin Talbot
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

Review 9.  DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Authors:  Jannigje Rachel Kok; Nelma M Palminha; Cleide Dos Santos Souza; Sherif F El-Khamisy; Laura Ferraiuolo
Journal:  Cell Mol Life Sci       Date:  2021-06-26       Impact factor: 9.261

10.  Translation of the poly(GR) frame in C9ORF72-ALS/FTD is regulated by cis-elements involved in alternative splicing.

Authors:  Alexa Lampasona; Sandra Almeida; Fen-Biao Gao
Journal:  Neurobiol Aging       Date:  2021-05-08       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.